CARA Cara Therapeutics, Inc.

+0.23  (1.58%)
Previous Close 14.53
Open 14.53
Price To book 5.52
Market Cap 402.68M
Shares 27,282,000
Volume 1,359,121
Short Ratio 11.24
Av. Daily Volume 1,516,700

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 initiated September 2015. Placed on clinical hold February 2016. Clinical hold released April 2016 with enrolment resuming June 2016. Interim conditional power analysis due 1H 2017.
IV CR845
Acute pain
Phase 2b trial initiated September, 2016. Data are due 1H 2017.
Osteoarthritis (OA)
Phase 2/3 completion of enrollment announced November 29, 2016 with top-line data due 1Q 2017.
IV CR845
Uremic pruritus

Latest News

  1. 3 Biotech Stocks to Buy in February
  2. Here's What 'Superinvestors' Are Doing During the Latest Surge in the Stock Market
  3. Why Shares of Cara Therapeutics Are Up Over 75% Since the Start of 2017
  4. How High Can Cara Therapeutics Stock Go?
  5. What Will Jeff Sessions Mean for the Marijuana Industry?
  6. Why Cara Therapeutics Stock Gained 57% in January
  7. Harry Boxer: Watch these two biotechnology stocks
  8. AMD Shows Strength, Weakness Continues For Carter's
  9. Cara Therapeutics (CARA) Worth Watching: Stock Jumps 8%
  10. Biotech M&A Activity Expected to Rise in 2017: Latest Reports on Pulmatrix and Cara Therapeutics
  11. This Little Biotech Could Have a Big Winner on Its Hands
  12. Top 4 Medicinal Marijuana Stocks for 2017
  13. Donald Trump On Weed Legalization: What’s In Store For Marijuana Stocks?
  14. ETFs with exposure to CARA Therapeutics, Inc. : January 11, 2017
  15. The 2016 Election Was A Tipping Point For Marijuana Stocks
  16. 3 Companies Whose Revenue Could Double in 2017
  17. Will 2017 Be a Breakout Year for Cara Therapeutics?
  18. How Does Cara Therapeutics Inc (CARA) Stack Up Against Its Peers?
  19. The Worst Marijuana Stocks in 2016
  20. Cara Therapeutics Completes Planned Enrollment of Eight-Week Multi-Dose Phase of Adaptive Trial of I.V. CR845 in Chronic Kidney Disease-Associated Pruritus